Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 26 Apr 2023
The dreaded hay fever signs, including itchy eyes, sneezing, and a stuffy nose, have arrived for many people with the arrival of spring. Up to 42% of people experience hay fever, making it a widespread condition. Immune system overreaction is the cause of it.
Read Full NewsRoshen Mathew, MD, DAABIP, discusses STABLE, in which diagnostic yield was 86.8% with breath-hold vs 92.2% with conventional ventilation.
Sara Cuccurullo, MD, FAAPMR, and Talya Fleming, MD, FAAPMR, of Hackensack Meridian JFK Johnson Rehabilitation Institute, discuss the updated adult stroke rehabilitation and recovery guidelines and their implications for clinical practice.
1.
Is Shorter Radiation Linked to Lymphedema in Breast Cancer?
2.
Canine Cancer Vaccine: A Potential Resurrection? U.S. KK. Snubs Enertu.
3.
Checking PSA levels too soon after prostate cancer surgery can lead to overtreatment, study suggests
4.
Cancer Drug Shortages Continue With No Immediate Path Toward Relief
5.
GLP-1 drugs linked to dramatically lower death rates in colon cancer patients
1.
The Power of Salt Tablets: Unlocking Health Benefits Beyond Sodium
2.
Menstrual Blood Changes in Iron-Deficiency States: Clinical Insights and Evidence-Based Management
3.
Boosting Checkpoint Immunotherapy in Hodgkin Lymphoma with JAK Inhibition: Advances & Insights
4.
The Digital Biopsy: How Artificial Intelligence is Redefining Cancer Pathology?
5.
Seeing the Unseen: Examining Chancroid Through Images
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
3.
How Nutrition Can Support Patients During Cancer Care
4.
Navigating the Complexities of Ph Negative ALL - Part XVI
5.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge